135
Views
12
CrossRef citations to date
0
Altmetric
Drug Profile

Establishing the role of tigecycline in an era of antimicrobial resistance

&
Pages 557-567 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Burke A. Cunha, Jeffrey Baron & Cheston B. Cunha. (2017) Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited. Expert Review of Anti-infective Therapy 15:3, pages 257-267.
Read now
Alexandre P Zavascki, Cecília G Carvalhaes, Renata C Picão & Ana C Gales. (2010) Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Review of Anti-infective Therapy 8:1, pages 71-93.
Read now

Articles from other publishers (10)

Lucija Slemc, Špela Pikl, Hrvoje Petković & Martina Avbelj. 2021. Antimicrobial Therapies. Antimicrobial Therapies 303 330 .
Jeffrey Baron, Shuntao Cai, Natalie Klein & Burke Cunha. (2018) Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness. Journal of Clinical Medicine 7:3, pages 49.
Crossref
Chaitra ShankarLaura E. B. NabarroShalini AnandanBalaji Veeraraghavan. (2017) Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram–Negative Organisms?. Microbial Drug Resistance 23:4, pages 437-446.
Crossref
B Veeraraghavan, C Shankar & S Vijayakumar. (2016) Can minocycline be a carbapenem sparing antibiotic? Current evidence. Indian Journal of Medical Microbiology 34:4, pages 513-515.
Crossref
Cecilia Godoy Carvalhaes, Rodrigo Cayô & Ana Cristina Gales. (2013) Klebsiella pneumoniae Carbapenemase-Producing Klebsiella Pneumoniae in the Intensive Care Unit. Shock 39:Supplement 1, pages 32-37.
Crossref
Soo-Youn MoonKyong Ran PeckHyun-Ha ChangShin-Woo KimSang Taek HeoJun Seong SonSeong Yeol RyuChisook MoonSook-In JungSang Yop ShinJeong-a LeeMi-Kyong JoungDoo-Ryeon ChungCheol-In KangJae-Hoon Song. (2012) Clinical Experience of Tigecycline Treatment in Infections Caused by Extensively Drug-Resistant Acinetobacter spp. . Microbial Drug Resistance 18:6, pages 562-566.
Crossref
Efthimia Tasina, Anna-Bettina Haidich, Stamatia Kokkali & Malamatenia Arvanitidou. (2011) Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. The Lancet Infectious Diseases 11:11, pages 834-844.
Crossref
M.-F. Bonilla, R. K. Avery, S. J. Rehm, E. A. Neuner, C. M. Isada & D. van Duin. (2011) Extreme alkaline phosphatase elevation associated with tigecycline. Journal of Antimicrobial Chemotherapy 66:4, pages 952-953.
Crossref
V. Cattoir & C. Daurel. (2010) Quelles nouveautés en antibiothérapie ?. Médecine et Maladies Infectieuses 40:3, pages 135-154.
Crossref
Gayatri Vedantam. (2009) Antimicrobial resistance in Bacteroides spp.: occurrence and dissemination . Future Microbiology 4:4, pages 413-423.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.